Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05554471 · ClinicalTrials.gov registry record · NA
Evaluation of Safety and Efficacy of the Mynx Control Venous Vascular Closure Device 6F-12F vs Manual Compression
A NA study, sponsored by Cordis US.
- Completed
- Registry status
- NA
- Development phase
- 352
- Enrollment target
NCT05554471 is a NA study that has completed, run by Cordis US. The registered enrollment target is 352 participants.
The verdict
NCT05554471, a NA study, has completed, sponsored by Cordis US.
- COMPLETED
- Registry status
- NA
- Development phase
- 352 participants
- Enrollment target
Study Summary
ReliaSeal is a clinical trial designed to evaluate safety and efficacy of use of MYNX CONTROL™ Venous Vascular Closure Device 6F-12F vs. manual compression to seal femoral access sites in patients who have undergone endovascular procedures utilizing up to 12F procedural sheaths in one or both limbs.
Interventions
- DEVICE MYNX CONTROL™ Venous Vascular Closure Device 6F-12F
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 352 participants |
| Start Date | 2022-08-30 |
| Est. Completion | 2023-07-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05554471
The ClinicalTrials.gov registry entry for NCT05554471 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 352 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cordis US, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MYNX CONTROL™ Venous Vascular Closure Device 6F-12F is the first listed.
NCT05554471 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05554471 about?
NCT05554471 is a clinical study titled "Evaluation of Safety and Efficacy of the Mynx Control Venous Vascular Closure Device 6F-12F vs Manual Compression". ReliaSeal is a clinical trial designed to evaluate safety and efficacy of use of MYNX CONTROL™ Venous Vascular Closure Device 6F-12F vs. manual compression to seal femoral access sites in patients who have undergone endovascular procedures utilizing up to 12F procedural sheaths in one or both limbs.
What is the current status of trial NCT05554471?
This trial is currently completed. It is a NA study. The enrollment target is 352 participants. The study started on 2022-08-30. Estimated completion is 2023-07-11.
What interventions are being tested in trial NCT05554471?
The interventions under investigation include: MYNX CONTROL™ Venous Vascular Closure Device 6F-12F (DEVICE).
Who is sponsoring clinical trial NCT05554471?
This trial is sponsored by Cordis US, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.